The exosome therapeutics market is projected to grow at an annualized rate of 41%
Driven by the development of novel platforms and advanced technologies along with consistent efforts of the stakeholders in research and development of exosome therapeutics which is set to see some FDA approved therapies in this decade
Roots Analysis has announced the addition of “Exosome Therapeutics Market, 2022-2040” report to its list of offerings.
With the advancements in technologies developing targeted drug delivery therapies, the researchers are shifting their focus on exosomes as therapeutic drug interventions and drug delivery carriers. The growing interest in exploring exosomes for therapeutic purposes can be attributed to their ability to enter the respective organs, manifesting best results even in a weakened immune system and be stored for longer periods of time, owing to their greater life span. Driven by the ongoing pace of innovation and sufficient financial support from investors, the exosome therapeutics market is anticipated to witness substantial growth in t